Skip to main content
SpringerLink
Log in

Manches bleibt - vieles ändert sich

Leitlinie Gastroösophageale Refluxkrankheit 2022: Was ist neu?

Guideline gastroesopageal reflux disease 2022 - what´s new?

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin, Diakonie-Klinikum GmbH/Jung-Stilling-Krankenhaus, Wichernstraße 40, 57074, Siegen, Deutschland

    Joachim Labenz

Authors
  1. Joachim Labenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim Labenz.

Ethics declarations

Honorare für Beratung und Vorträge von Bayer, Falk, Implantica, Luvos, Reckitt Benckiser, Schwabe; Forschungsunterstützung Reckitt Benckiser, Sofar

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Labenz, J. Leitlinie Gastroösophageale Refluxkrankheit 2022: Was ist neu?. MMW - Fortschritte der Medizin 164, 40–45 (2022). https://doi.org/10.1007/s15006-022-1890-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-022-1890-z

Keywords:

Search

Navigation